Kymera Therapeutics, Inc. (KYMR) — SC 13G/A Filings

SC 13G/A Filings (12)

• SC 13G/A Filing — Nov 14, 2024
• SC 13G/A Filing — Nov 14, 2024
• SC 13G/A Filing — Nov 14, 2024
• SC 13G/A Filing — Nov 8, 2024
• SC 13G/A Filing — Feb 14, 2024
• SC 13G/A Filing — Feb 13, 2024
• T. Rowe Price Maintains 9.6% Stake in Kymera Therapeutics — Feb 12, 2024 Risk: low
  T. Rowe Price Associates, Inc. filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Kymera Therapeutics, Inc. As of December 31, 2023, T.
• Atlas Venture Fund X Amends Kymera Therapeutics Stake — Feb 9, 2024 Risk: low
  Atlas Venture Fund X, L.P. filed an amended Schedule 13G/A on February 9, 2024, indicating a change in their beneficial ownership of Kymera Therapeutics, Inc. c
• Wellington Management Group LLP Amends Kymera Therapeutics Stake — Feb 8, 2024 Risk: low
  Wellington Management Group LLP, a major investment firm, filed an amended SC 13G/A on February 8, 2024, disclosing its ownership in Kymera Therapeutics, Inc. a
• BlackRock Amends Kymera Therapeutics Stake, Remains Passive Investor — Jan 29, 2024
  BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Kymera Therapeutics, Inc. common stock as of December 31, 2023. This f
• State Street Corp. Updates Passive Stake in Kymera Therapeutics — Jan 23, 2024
  State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 23, 2024, indicating its ownership of Kymera Therapeutics, I
• Baker Bros. Advisors LP Amends Kymera Therapeutics Stake — Jan 10, 2024
  Baker Bros. Advisors LP, a Delaware-based investment firm, filed an amended SC 13G/A on January 10, 2024, disclosing their beneficial ownership of Kymera Therap

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX